Association study of GRIK1 gene polymorphisms in schizophrenia: Case-control and family-based studies

Human Psychopharmacology

Volumn 27, Issue 4, 2012, Pages 345-351

  Hirata, Yuko ^a   Zai, Clement C ^a,b   Souza, Renan P ^c   Lieberman, Jeffrey A ^d   Meltzer, Herbert Y ^e   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

case control; family based association study; genetics; GluR5 glutamate receptor ionotropic kainate 1 gene (GRIK1); schizophrenia

Indexed keywords

GENOMIC DNA; GLUTAMATE RECEPTOR IONOTROPIC KAINATE 1; IONOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR FAMILY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HUMANS; MALE; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KAINIC ACID; SCHIZOPHRENIA;

EID: 84864122527     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2233     Document Type: Article

References (47)

1. Aickin M,. 1999. Other method for adjustment of multiple testing exists. BMJ 318: 127-128.
2. Altshuler D, Kruglyak L, Lander E,. 1998. Genetic polymorphisms and disease. N Engl J Med 338 (22): 1626.
3. Badner JA, Gershon E,. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405-411.
4. Barbon A, Barlati S,. 2000. Genomic organization, proposed alternative splicing mechanisms, and RNA editing structure of GRIK1. Cytogenet Cell Genet 88 (3-4): 236-239.
5. Barrett JC, Fry B, Maller J, Daly MJ,. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
6. Basu AC, Tsai GE, Ma CL, et al,. 2009. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry 14 (7): 719-727.
7. Bender R, Lange S,. 1999. Multiple test procedures other than Bonferroni's deserve wider use. BMJ 318: 600-601.
8. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH,. 2007. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32 (9): 1888-1902.
9. Bettler B, Mulle C,. 1995. Neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology 34 (2): 123-139.
10. Dracheva S, Byne W, Chin B, Haroutunian V,. 2008. Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia. Brain Res 1214: 23-34.
11. Dudbridge F,. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.
12. Freedman R,. 2003. Schizophrenia. N Engl J Med 349: 1738-1749.
13. Gottesman II, McGuffin P, Farmer AE,. 1987. Clinical genetics as clues to the "real" genetics of schizophrenia. Schizophr Bull 13: 23-47.
14. Harrison PJ, Weinberger DR,. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68.
15. Henley JM,. 1994. Kainate-binding proteins: phylogeny, structures and possible functions. Trends Pharmacol Sci 15: 182-190.
16. Hodgkinson CA, Yuan Q, Xu K, et al,. 2008. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43 (5): 505-515.
17. Hovarth S, Xu X, Laird NM,. 2001. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9: 304-306.
18. Javitt DC, Zukin SR,. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (10): 1301-1308.
19. Jentsch JD, Roth RH,. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (3): 201-225.
20. Jiang L, Xu J, Nedergaard M, Kang J,. 2001. A kainate receptor increases the efficacy of GABAergic synapses. Neuron 30 (2): 503-513.
21. Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, St George-Hyslop P,. 2003. The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302: 822-826.
22. Krivoy A, Fischel T, Weizman A,. 2008. The possible involvement of metabotropic glutamate receptors in schizophrenia. Eur Neuropsychopharmacol 18 (6): 395-405.
23. Lahiri DK, Nurnberger JI Jr,. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (19): 5444.
24. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J,. 2007. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20: 687-702.
25. Leong D, Puil E, Schwarz D,. 2004. Ketamine blocks non-N-methyl-D- aspartate receptor channels attenuating glutamatergic transmission in the auditory cortex. Acta Otolaryngol 124 (4): 454-458.
26. Lewis CM, Levinson DF, Wise LH, et al,. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73: 34-48.
27. Li J, Ji L,. 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95 (3): 221-227.
28. Martucci L, Wong AH, Trakalo J, et al,. 2003. N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am J Med Genet B Neuropsychiatr Genet 119B (1): 24-27.
29. Martucci L, Wong AH, De Luca V, et al,. 2006. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels. Schizophr Res 84 (2-3): 214-221.
30. Moghaddam B, Adams BW,. 1998. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
31. Moghaddam B, Adams B, Verma A, Daly D,. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
32. Norton N, Williams HJ, Owen MJ,. 2006. An update on the genetics of schizophrenia. Curr Opin Psychiatry 19: 158-164.
33. Perneger TV,. 1998. What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
34. Petronis A,. 2004. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55: 965-970.
35. Purcell S, Cherny SS, Sham PC,. 2003. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (1): 149-150.
36. Qiu CS, Lash-Van Wyhe L, Sasaki M, Sakai R, Swanson GT, Gereau RW, 4th,. 2011. Antinociceptive effects of MSVIII-19, a functional antagonist of the GluK1 kainate receptor. Pain 152 (5): 1052-1060.
37. Riley B, Kendler KS,. 2006. Molecular genetic studies of schizophrenia. Eur J Hum Genet 14: 669-680.
38. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT,. 2006. Neurobiology of schizophrenia. Neuron 52: 139-153.
39. Scarr E, Beneyto M, Meador-Woodruff JH, Deans B,. 2005. Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology 30 (8): 1521-1531.
40. Shi J, Levinson DF, Duan J, et al,. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460 (7256): 753-757.
41. Shibata H, Joo A, Fujii Y, et al,. 2001. Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia. Psychiatr Genet 11 (3): 139-144.
42. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, Iyengar S,. 1998. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37 (1): 25-36.
43. Stefansson H, Genetic Risk and Outcome in Psychosis (GROUP), Kahn RS, et al,. 2009. Common variants conferring risk of schizophrenia. Nature 460 (7256): 744-747.
44. Steinpreis RE, Salamone JD,. 1993. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microanalysis and behavioral study. Brain Res 612: 263-270.
45. Sun J, Kuo P, Riley BP, Kendler KS, Zhao Z,. 2008. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Amer J Med Genet 147B: 1173-1181.
46. Xu Z, Taylor JA,. 2009. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 3. DOI: 10.1093/nar/gkp290
47. Zai CC, Tiwari A, King N, et al,. 2009. The gamma-aminobutyric acid type A receptor γ2 subunit gene GABRG2 is associated with schizophrenia. Schizophr Res 114 (1-3): 33-38.